INVO Fertility (IVF) Operating Expenses (2011 - 2026)

INVO Fertility (IVF) has 16 years of Operating Expenses data on file, last reported at $3.6 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 27.13% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $11.9 million, a 17.75% decrease from a year earlier, with the FY2024 full-year figure at $14.7 million, up 49.75% from the prior year.
• Operating Expenses for Q1 2026 stood at $3.6 million, up from $3.4 million in the prior quarter.
• Over the last five years, Operating Expenses for IVF reached as high as $5.2 million in Q4 2024 and fell as low as $1.9 million in Q3 2023.
• Historically, Operating Expenses has averaged $3.2 million across 5 years, with a median of $2.9 million in 2023.
• Across the five-year window, Operating Expenses sank 32.58% in 2023 and jumped 78.19% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $3.0 million in 2022, then declined by 3.54% to $2.9 million in 2023, then soared by 78.19% to $5.2 million in 2024, then plunged by 34.13% to $3.4 million in 2025, then climbed by 6.3% to $3.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $3.6 million in Q1 2026, $3.4 million in Q3 2025, and $4.9 million in Q2 2025.